Starlight Cardiovascular
PrivateLast Round
Grant
Sep 15, 2024
Total Funding Raised
$14.16M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Starlight Cardiovascular is a medical technology company that develops a portfolio of devices specifically designed to address pediatric Congenital Heart Disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Starlight Cardiovascular Comparables
Compare Starlight Cardiovascular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Renata Medical | 89% | |
| NuMED | 84% | |
| PolyVascular, Inc. | 82% |
Starlight Cardiovascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 15, 2024 | ||||
| Grant | May 1, 2024 | ||||
| Grant | Mar 22, 2023 | ||||
| Series A | Oct 4, 2022 | ||||
| Seed | Jul 1, 2021 | ||||
Accelerator | Mar 26, 2021 |
Starlight Cardiovascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Seed |
| Catalytic Impact Foundation | VC Round, Seed, Series A |
| Realize Impact | Seed, Series A |
| BIRD B. AG | Series A |
| The Consortium for Technology & Innovation in Pediatrics | Seed |
| National Heart, Lung, and Blood Institute | Grant |
| UCSF-Stanford Pediatric Device Consortium | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Open roles increased to 7, representing 58% of headcount.
- Jul 20, 2026
Open roles increased to 4, 3x the trailing average.
Starlight Cardiovascular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Starlight Cardiovascular's valuation, stock price, and market status.
Is Starlight Cardiovascular a public or private company?
Starlight Cardiovascular is a private company.
What is the current stock price of Starlight Cardiovascular?
Starlight Cardiovascular is a private company with no public stock price. No recent secondary market data is available.
How much is Starlight Cardiovascular worth (valuation)?
Valuation information for Starlight Cardiovascular is not publicly available.
Can I buy Starlight Cardiovascular stock?
Starlight Cardiovascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Starlight Cardiovascular's last funding round?
Funding round information for Starlight Cardiovascular is not publicly available.
Who are the main investors in Starlight Cardiovascular?
Investor information for Starlight Cardiovascular is not publicly disclosed.
Will Starlight Cardiovascular IPO soon?
No public IPO plans have been announced for Starlight Cardiovascular.
How can I track Starlight Cardiovascular secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Starlight Cardiovascular's secondary market activity and sign up for updates.